MENLO
PARK, Calif., Sept. 7,
2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading
developer of high-quality, highly accurate sequencing solutions,
announced today that it will be participating in the upcoming
Morgan Stanley 20th Annual Global Healthcare Conference in
New York, New York.
Members of PacBio's management are scheduled to participate in a
fireside chat on Wednesday, September
14 at 1:30 p.m. Eastern Time.
The live webcast can be accessed at the company's investors page at
investor.pacificbiosciences.com. A replay of the webcast will be
available for at least 30 days following the presentation.
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier
life science technology company that is designing, developing and
manufacturing advanced sequencing solutions to help scientists and
clinical researchers resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality and
completeness which include our existing HiFi long read sequencing
and our emerging SBB™ short read sequencing technologies. Our
products address solutions across a broad set of research
applications including human germline sequencing, plant and animal
sciences, infectious disease and microbiology, oncology, and other
emerging applications. For more information, please visit
www.pacb.com and follow @PacBio.
Contacts
Investors:
Todd
Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference-301619599.html
SOURCE Pacific Biosciences of California, Inc.